GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 33 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2013 | $2,000 | – | 212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benchmark Capital Advisors | 221,700 | $1,051,000 | 0.83% |
| EAM Global Investors LLC | 227,063 | $1,076,000 | 0.56% |
| EAM Investors, LLC | 319,187 | $1,513,000 | 0.25% |
| COURAGE CAPITAL MANAGEMENT LLC | 30,000 | $142,000 | 0.11% |
| Cutter & CO Brokerage, Inc. | 53,600 | $254,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 286,800 | $1,360,000 | 0.08% |
| D.A. DAVIDSON & CO. | 731,300 | $3,466,000 | 0.07% |
| Tibra Equities Europe Ltd | 63,414 | $301,000 | 0.05% |
| Advisor Group, Inc. | 556,377 | $2,637,000 | 0.04% |
| Laurel Wealth Advisors, Inc. | 21,400 | $101,000 | 0.03% |